- Home
- DRUG vs WHF Comparison
DRUG vs WHF Comparison
Compare DRUG & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- WHF
- Stock Information
- Founded
- DRUG 2019
- WHF 2011
- Country
- DRUG United States
- WHF United States
- Employees
- DRUG N/A
- WHF N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- WHF Finance Companies
- Sector
- DRUG Health Care
- WHF Finance
- Exchange
- DRUG Nasdaq
- WHF Nasdaq
- Market Cap
- DRUG 260.6M
- WHF 229.4M
- IPO Year
- DRUG N/A
- WHF 2012
- Fundamental
- Price
- DRUG $37.65
- WHF $10.32
- Analyst Decision
- DRUG Strong Buy
- WHF Sell
- Analyst Count
- DRUG 4
- WHF 4
- Target Price
- DRUG $84.33
- WHF $11.00
- AVG Volume (30 Days)
- DRUG 91.2K
- WHF 72.7K
- Earning Date
- DRUG 12-31-2024
- WHF 02-27-2025
- Dividend Yield
- DRUG N/A
- WHF 17.27%
- EPS Growth
- DRUG N/A
- WHF N/A
- EPS
- DRUG N/A
- WHF 0.45
- Revenue
- DRUG N/A
- WHF $97,441,000.00
- Revenue This Year
- DRUG N/A
- WHF N/A
- Revenue Next Year
- DRUG N/A
- WHF N/A
- P/E Ratio
- DRUG N/A
- WHF $23.21
- Revenue Growth
- DRUG N/A
- WHF N/A
- 52 Week Low
- DRUG $0.93
- WHF $9.45
- 52 Week High
- DRUG $79.02
- WHF $13.44
- Technical
- Relative Strength Index (RSI)
- DRUG 55.50
- WHF 63.60
- Support Level
- DRUG $28.21
- WHF $10.49
- Resistance Level
- DRUG $38.00
- WHF $10.64
- Average True Range (ATR)
- DRUG 2.86
- WHF 0.15
- MACD
- DRUG 0.45
- WHF 0.08
- Stochastic Oscillator
- DRUG 96.42
- WHF 86.11
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries.